QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.
Goal to reach global capacity for RNA nucleic extraction workflows for over 10 million patient tests a month by end of June 2020 and to reach capacity for 20 million monthly patient tests by end of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Percepta Associates announces release of its Series One Nucleic Acid Purification (China) Life Science Dashboard™ market research report revealing Tiangen, Qiagen ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Building ...
New kits reduce use of plastics by up to 62% and cardboard by up to 58% compared to QIAGEN standard kits // Two additions to growing QIAwave portfolio: QIAwave RNeasy Plus Mini Kit and QIAwave DNA/RNA ...
VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)--Aug. 27, 2026-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an ...
"Clinical laboratories need automation solutions that combine proven extraction performance with the standardization, traceability and productivity needed for today's molecular testing workflows," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results